Ticker Symbol: STRO
Sutro Biopharma Inc
$19.03 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001382101
Company Profile
Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: 310 Utah Ave Ste 150
Website: www.sutrobio.com
CEO: William Newell
Tags:
- Health Technology
- Pharmaceuticals: Major
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $3.06
Change:
-$0.44
(
-12.57%)
Days Range: $3.03 - $3.52
Beta: 0.72
52wk. High: $8.72
52wk. Low: $3.03
Ytd. Change -69.25%
50 Day Moving Average: $3.78
200 Day Moving Average: $4.55
Shares Outstanding: 60500000
Valuation
Market Cap: 18.5B
PE Ratio: -
EPS (TTM): -2.5
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A